BTAI

BTAI

USD

BioXcel Therapeutics Inc. Common Stock

$1.860-0.020 (-1.064%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$1.880

High

$2.000

Low

$1.840

Volume

0.61M

Company Fundamentals

Market Cap

36.5M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

6.89M

Exchange

NCM

Currency

USD

52-Week Range

Low $1.17Current $1.860High $12.16

Related News

GlobeNewswire

BioXcel Therapeutics to Ring Nasdaq Closing Bell on October 14 to Celebrate a Transformative Milestone in Neuroscience Innovation

NEW HAVEN, Conn., Oct. 13, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (NASDAQ:BTAI), a biopharmaceutical company pioneering the use of artificial intelligence to develop transformative medicines in

View more
BioXcel Therapeutics to Ring Nasdaq Closing Bell on October 14 to Celebrate a Transformative Milestone in Neuroscience Innovation